Roivant Sciences Ltd

ROIVNASDAQ · US

Holders

ACQUIREDT+2
Sukhatme Mayukh
Roivant Sciences Ltd · NASDAQ
+17,519 sh · $67.4K
Filed 21 Aug 2026SEC Form 4view source
ACQUIREDT+2
Sukhatme Mayukh
Roivant Sciences Ltd · NASDAQ
+172,899 sh · $665.7K
Filed 21 Aug 2026SEC Form 4view source
ACQUIREDT+2
Sukhatme Mayukh
Roivant Sciences Ltd · NASDAQ
+144,756 sh · $557.3K
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Sukhatme Mayukh
Roivant Sciences Ltd · NASDAQ
−172,899 sh · $6.4M
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Sukhatme Mayukh
Roivant Sciences Ltd · NASDAQ
−144,756 sh · $5.3M
Filed 21 Aug 2026SEC Form 4view source
REDUCEDT+2
Sukhatme Mayukh
Roivant Sciences Ltd · NASDAQ
−17,519 sh · $653.5K
Filed 21 Aug 2026SEC Form 4view source
DISCLOSEDQuarterly
Viking Global Investors
Roivant Sciences Ltd · NASDAQ
6,271,467 sh · $221.9M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Viking Global Investors
Roivant Sciences Ltd · NASDAQ
6,652,448 sh · $184.3M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Roivant Sciences Ltd · NASDAQ
6,443,191 sh · $139.8M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Viking Global Investors
Roivant Sciences Ltd · NASDAQ
23,594,831 sh · $357.0M
Filed 30 Sept 2025SEC 13Fview source